📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen. (2016)

First Author: De Tute RM

Attributed to: Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2015.128215

PubMed Identifier: 26471484

Publication URI: http://europepmc.org/abstract/MED/26471484

Type: Journal Article/Review

Volume: 101

Parent Publication: Haematologica

Issue: 2

ISSN: 0390-6078